ANAPC15P1

Across TCGA pan-cancer cohorts, ANAPC15P1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ANAPC15P1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where ANAPC15P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ANAPC15P1 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

COAD, KIRC, and LIHC are the cancer types where ANAPC15P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ANAPC15P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.299	.005	5	view →
KIRC	Male	All	−0.022	.014	3	view →
LIHC	Male	All	+0.028	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

ANAPC15P1–COAD

Open the COAD breakdown →